Search Results

There are 1129 results for: content related to: Alpha 1 Adrenoreceptor Antagonists

  1. Enantioselective Pharmacokinetics of Doxazosin and Pharmacokinetic Interaction Between the Isomers in Rats

    Chirality

    Volume 27, Issue 10, October 2015, Pages: 738–744, Qing Li, Dezhi Kong, Qian Du, Jing Zhao, Yaqin Zhen, Tonghui Li and Leiming Ren

    Version of Record online : 23 JUL 2015, DOI: 10.1002/chir.22483

  2. Finasteride for benign prostatic hyperplasia

    Intervention Review

    The Cochrane Library

    James Tacklind, Howard A Fink, Roderick MacDonald, Indy Rutks and Timothy J Wilt

    Published Online : 6 OCT 2010, DOI: 10.1002/14651858.CD006015.pub3

  3. The α1-Adrenergic Receptor Antagonist, Doxazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 2, February 2013, Pages: 202–212, Meghan L. O'Neil, Lauren E. Beckwith, Carrie L. Kincaid and Dennis D. Rasmussen

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1530-0277.2012.01884.x

  4. You have free access to this content
    A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia

    BJU International

    Volume 87, Issue 3, February 2001, Pages: 192–200, R.S. Kirby, M. Andersen, P. Gratzke, C. Dahlstrand and K. Høye

    Version of Record online : 16 JUL 2009, DOI: 10.1046/j.1464-410x.2001.02032.x

  5. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion

    Journal of Cellular Biochemistry

    Volume 94, Issue 2, 1 February 2005, Pages: 374–388, Kaspar Keledjian, Jason B. Garrison and Natasha Kyprianou

    Version of Record online : 3 NOV 2004, DOI: 10.1002/jcb.20240

  6. You have free access to this content
    Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation

    British Journal of Clinical Pharmacology

    Volume 48, Issue 5, November 1999, Pages: 678–687, Chung, Vashi, Puente, Sweeney and Meredith

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00067.x

  7. You have free access to this content
    The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia

    BJU International

    Volume 95, Issue 4, March 2005, Pages: 575–579, John M. Fitzpatrick and François Desgrandchamps

    Version of Record online : 10 FEB 2005, DOI: 10.1111/j.1464-410X.2005.05342.x

  8. You have free access to this content
    Assessment of α1-adrenoceptor antagonists in benign prostatic hyperplasia based on the receptor occupancy theory

    British Journal of Clinical Pharmacology

    Volume 63, Issue 4, April 2007, Pages: 394–403, Kaori Ito, Hisakazu Ohtani and Yasufumi Sawada

    Version of Record online : 17 OCT 2006, DOI: 10.1111/j.1365-2125.2006.02783.x

  9. You have free access to this content
    Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects

    BJU International

    Volume 94, Issue 9, December 2004, Pages: 1263–1270, Roderick MacDonald, Timothy J. Wilt and R. William Howe

    Version of Record online : 6 DEC 2004, DOI: 10.1111/j.1464-410X.2004.05154.x

  10. Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial

    Addiction Biology

    Volume 21, Issue 4, July 2016, Pages: 904–914, George A. Kenna, Carolina L. Haass-Koffler, William H. Zywiak, Steven M. Edwards, Michael B. Brickley, Robert M. Swift and Lorenzo Leggio

    Version of Record online : 2 JUN 2015, DOI: 10.1111/adb.12275

  11. Blood pressure lowering efficacy of alpha blockers for primary hypertension

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Brandon P Galm and James M Wright

    Published Online : 15 AUG 2012, DOI: 10.1002/14651858.CD004643.pub3

  12. Relative cytotoxic potencies and cell death mechanisms of α1-adrenoceptor antagonists in prostate cancer cell lines

    The Prostate

    Volume 76, Issue 8, June 1, 2016, Pages: 757–766, Amanda Forbes, Shailendra Anoopkumar-Dukie, Russ Chess-Williams and Catherine McDermott

    Version of Record online : 16 FEB 2016, DOI: 10.1002/pros.23167

  13. Hemodynamic Interaction Between a Daily Dosed Phosphodiesterase 5 Inhibitor, Tadalafil, and the α-Adrenergic Blockers, Doxazosin and Tamsulosin, in Middle-Aged Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1303–1310, Dr Michel Guillaume, Dr Finnuala Lonsdale, Ms Christelle Darstein, Dr Maria C. Jimenez and Dr Malcolm I. Mitchell

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007306559

  14. Combination of Doxazosin and Sildenafil Exerts an Additive Relaxing Effect Compared with Each Compound Alone on Human Cavernosal and Prostatic Tissue

    The Journal of Sexual Medicine

    Volume 6, Issue 3, March 2009, Pages: 836–847, Stéphanie Oger, Delphine Behr-Roussel, Diane Gorny, Olivier Lecoz, Thierry Lebret, Yves Denoux, Antoine Faix, Albert Leriche, Chris Wayman, Laurent Alexandre and François Giuliano

    Version of Record online : 23 DEC 2008, DOI: 10.1111/j.1743-6109.2008.01138.x

  15. You have free access to this content
    Comparative efficacy of two α1-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement

    BJU International

    Volume 93, Issue 6, April 2004, Pages: 757–762, T.M. De Reijke and P. Klarskov

    Version of Record online : 25 MAR 2004, DOI: 10.1111/j.1464-410X.2003.04720.x

  16. Effects of the inverse alpha-agonist doxazosin in allergic rhinitis

    Clinical & Experimental Allergy

    Volume 46, Issue 5, May 2016, Pages: 696–704, A. Manoharan, A. E. Morrison and B. J. Lipworth

    Version of Record online : 26 APR 2016, DOI: 10.1111/cea.12700

  17. You have free access to this content
    Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid

    British Journal of Pharmacology

    Volume 167, Issue 7, December 2012, Pages: 1563–1572, J Jehle, I Staudacher, F Wiedmann, PA Schweizer, R Becker, HA Katus and D Thomas

    Version of Record online : 6 NOV 2012, DOI: 10.1111/j.1476-5381.2012.02117.x

  18. You have free access to this content
    Endothelial α1-adrenoceptors regulate neo-angiogenesis

    British Journal of Pharmacology

    Volume 153, Issue 5, March 2008, Pages: 936–946, M Ciccarelli, G Santulli, A Campanile, G Galasso, P Cervèro, G G Altobelli, V Cimini, L Pastore, F Piscione, B Trimarco and G Iaccarino

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707637

  19. You have free access to this content
    Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction

    BJU International

    Volume 95, Issue 1, January 2005, Pages: 103–109, Roger S. Kirby, Michael P. O'Leary and Culley Carson

    Version of Record online : 20 DEC 2004, DOI: 10.1111/j.1464-410X.2004.05252.x

  20. You have free access to this content
    Doxazosin and Congestive Heart Failure

    Congestive Heart Failure

    Volume 8, Issue 3, May/June 2002, Pages: 178–184, Domenic A. Sica

    Version of Record online : 12 JUN 2007, DOI: 10.1111/j.1527-5299.2002.00939.x